Healthcare Research Analysts

Comprehensive investigation, research, and thought are used by our analysts to create the best information and options for our clients.

Brett Fishbin

Medical Technology

Brett Fishbin is a Vice President and Equity Research Analyst for KeyBanc Capital Markets Inc. With the firm since 2017, he focuses his research on the Medical Technology sector.

Before his promotion to senior analyst, he was a Research Associate on KBCM’s healthcare team for six years, including five in MedTech. Brett's previous investment experience includes actively managing a portion of the University of Wisconsin’s endowment fund as part of the Applied Securities Program, as well as an internship at Heartland Advisors in Milwaukee.

Fishbin earned a Bachelor of Business Administration in finance and an master's degree in Applied Securities Analysis from the University of Wisconsin-Madison. He also holds the Series 7, 63, 86, and 87 industry certifications.

Medical Technology Companies Under Research Coverage

Company	Ticker
Alcon Inc.	ALC
The Cooper Companies, Inc.	COO
ICU Medical, Inc.	ICUI
Inspire Medical Systems, Inc.	INSP
Integer Holdings Corporation	ITGR
LeMaitre Vascular, Inc.	LMAT
ResMed Inc.	RMD
Sotera Health Company	SHC
STERIS plc	STE
UFP Technologies, Inc.	UFPT

Paul Knight, CFA

Life Science Technology, Bioproduction and Diagnostics

Paul Knight is a Managing Director and Equity Research Analyst for KeyBanc Capital Markets Inc. His research coverage focuses on Healthcare, specifically the Life Science Technology, Bioproduction, and Diagnostics sectors.

Prior to joining KeyBanc Capital Markets in fall 2020, Knight spent seven years as an Equity Research Analyst covering Life Science Technology at Janney, Montgomery & Scott in New York. Before that, he covered Life Science Technology for Credit Agricole Securities (CLSA) for three years. His previous professional experience includes being a founding partner and analyst at Thomas Weisel Partners Group (Stifel Financial), a senior analyst at Salomon Brothers, as well as a political analyst for NatWest Securities in New York and Washington, D.C., covering Food and Drug Administration and congressional committee meetings.

Knight earned an MBA in finance from George Washington University in Washington, D.C., and a Bachelor of Science in economics from the University of Nebraska. He is a Chartered Financial Analyst, and also holds the Series 7, 62, 86, and 87 industry licenses.

Knight has been ranked as a top research analyst multiple times by surveys including Institutional Investor, Greenwich Associates, and The Wall Street Journal. He has delivered keynote addresses for several significant industry events, such as the Analytical & Life Sciences and Industry Association CEO Roundtable and the American Chemical Society’s annual meeting.

Life Science Technology, Bioproduction & Diagnostics Companies Under Research Coverage

Company	Ticker
Agilent Technologies, Inc.	A
Alpha Teknova, Inc.	TKNO
Avantor, Inc.	AVTR
Avid Bioservices, Inc.	CDMO
Azenta, Inc.	AZTA
Bio-Techne Corporation	TECH
BioLife Solutions, Inc.	BLFS
Castle Biosciences, Inc.	CSTL
Cryoport, Inc.	CYRS
Danaher Corporation	DHR
Exagen Inc.	XGN
Gerresheimer AG	GXIG
Harvard Bioscience, Inc.	HBIO
Lonza Group AG	LONN
Maravai LifeSciences Holdings, Inc.	MRVI
Mesa Laboratories, Inc.	MLAB
Repligen Corporation	RGEN
Revvity, Inc.	RVTY
Sartorius AG	SATG
Standard BioTools Inc.	LAB
Stevanato Group S.p.A.	STVN
Thermo Fisher Scientific Inc.	TMO
Waters Corporation	WAT
West Pharmaceutical Services, Inc.	WST

Scott Schoenhaus

Healthcare Technology

Scott Schoenhaus is a Managing Director and Equity Research Analyst for KeyBanc Capital Markets Inc. With the firm since May 2022, he focuses on researching healthcare IT (HCIT) companies.

Prior to joining KeyBanc Capital Markets, Scott had been at Stephens Inc. for eight years, where he most recently served as a Managing Director and Senior Analyst on HCIT research coverage. Scott started his career in equity research as an Industrials Research Associate at Wolfe Research (airlines, freight & transportation) in 2011. In total, Scott has 15 years of experience in the financial industry, which includes work experience at Sanford Bernstein and Mezz Cap.

Scott earned an Bachelor’s degree in economics from Georgetown University. He also holds the Series 7, 63, 86 & 87 industry licenses.

Healthcare Technology Companies Under Research Coverage

Company	Ticker
AbCellera Biologics Inc.	ABCL
Absci Corporation	ABSI
Alight, Inc.	ALIT
Certara, Inc.	CERT
Doximity, Inc.	DOCS
GoodRx Holdings, Inc.	GDRX
Health Catalyst, Inc.	HCAT
HealthEquity, Inc.	HQY
LifeMD, Inc.	LFMD
ODDITY Tech Ltd.	ODD
Omnicell, Inc.	OMCL
Phreesia, Inc.	PHR
Progyny, Inc.	PGNY
R1 RCM Inc.	RCM
Recursion	RXRX
Schrodinger, Inc.	SDGR
Simulations Plus, Inc.	SLP
Teladoc Health, Inc.	TDOC
Veeva Systems, Inc.	VEEV

Obtain information about KeyBanc Capital Markets Inc. and its financial professionals. FINRA BrokerCheck

KeyBanc Capital Markets is a trade name under which corporate and investment banking products and services of KeyCorp^® and its subsidiaries, KeyBanc Capital Markets Inc., Member FINRA/SIPC, and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and its licensed securities representatives. Banking products and services are offered by KeyBank N.A.

KBCM Research LLC (“KeyBanc Capital Markets Research”), an SEC registered investment advisor, is a wholly owned subsidiary of KeyBanc Capital Markets Inc. KeyBanc Capital Markets Research provides objective and sophisticated Research Services, primarily in the form of published Research Reports, to an institutional client base in exchange for a cash fee. KBCM Research does not provide particularized investment advice with regard to any specific institutional client, on the basis of specific sector or company requests from a client. Our advisory relationship with our clients is strictly limited to the provision of Research Services, which are not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Additional information about KBCM Research LLC also is available on the SEC’s Investment Adviser Public Disclosure (IAPD) website.

Please read our complete KeyBanc Capital Markets disclosure statement.

Securities products and services: Not FDIC Insured • No Bank Guarantee • May Lose Value

Find an Expert

By Industry By Solution

Our Expertise

Business Expertise
Industry Expertise

Connect With Us

Find an Expert

By Industry By Solution

Our Expertise

Business Expertise
Industry Expertise